LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates
Portfolio Pulse from
LifeStance Health Group (LFST) reported a Q4 loss of $0.02 per share, which was better than the Zacks Consensus Estimate of a $0.04 loss. This is an improvement from the $0.12 loss per share reported a year ago.
February 27, 2025 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LifeStance Health Group reported a smaller-than-expected Q4 loss of $0.02 per share, beating the Zacks Consensus Estimate and showing improvement from last year's loss.
The better-than-expected earnings report is likely to positively impact LFST's stock price in the short term. The improvement from last year's loss indicates positive momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100